PET scan test for a dementia brain tracer
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This early-phase study tests a new PET scan tracer that targets a brain chemical transport system involved in dementia. It aims to see if the tracer can safely and clearly show brain changes, which could help future dementia diagnosis or tracking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 40 to 75
- You can give consent (or a legal representative can if needed) and will follow study steps
- You are healthy enough for the study and have no major physical problems that block testing
- Your arm blood vessels are suitable for a small catheter
- You do not smoke and are not using over-the-counter nicotine-cessation products
- You have not taken central nervous system medicine (brain-related prescription meds) for the past 3 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a PET scan “tracer” medicine called [18F]MK-6240 to see how tau protein changes show up in the brain. It may help researchers measure disease-related brain changes in people with normal thinking or mild dementia.
This study tests if a new radioactive tracer called [18F]-MFBG can help doctors better distinguish between Parkinson's disease, multiple system atrophy (MSA), dementia with Lewy bodies, and Alzheimer's disease. It compares the new scan with two standard scans to see which is most accurate.
This study uses brain scans (PET) to look at changes in the brain that may be related to memory problems or Alzheimer's disease. It aims to improve understanding of the disease and may help develop better treatments.
This study uses a special PET brain scan to look at two types of brain immune cells in people with Alzheimer’s. It may help researchers better understand Alzheimer’s and how these cells change over time.
This trial uses a special PET scan tracer to see if it can predict who will get worse over time. It is for people with mild memory or thinking problems that may be linked to past head injuries or early Alzheimer's disease.
This Phase 3 study uses a PET/CT scan to measure whether a brain protein called tau (and related disease patterns) builds up in different dementia conditions. The goal is to better match which disorders have which brain changes and how they progress.
Hear when a new Frontotemporal Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.